Ignite Creation Date:
2024-05-06 @ 8:44 AM
Last Modification Date:
2024-10-26 @ 12:04 PM
Study NCT ID:
NCT02802670
Status:
COMPLETED
Last Update Posted:
2016-06-16
First Post:
2016-05-26
Brief Title:
A Pharmacokinetic Study of 14C-GDC-0810 After Single Oral Administration in Healthy Female Participants
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2016-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an open-label non-randomized study to determine the excretion kinetics and mass balance of GDC-0810 and to determine metabolites present in blood feces and urine in healthy participants following a single 300-milligram mg oral dose of GDC-0810 containing approximately 100 microcuries of 14C labeled GDC-0810 using conventional absorption metabolism and excretion AME methodology The entire duration of the study is up to approximately 8 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None